Description

n-(4-Bromo-2-Fluorophenyl)-3-Methylbenzamide is a high-purity, advanced pharmaceutical intermediate characterized by its specific halogenated aromatic structure. This compound matters for its critical role as a key building block in the synthesis of complex active pharmaceutical ingredients (APIs), particularly in medicinal chemistry research and development. Pharmaceutical, agrochemical, and advanced material research companies need this precise intermediate to develop new drug candidates and specialty chemicals with targeted biological activity.

Application

• Pharmaceutical Intermediate: Serves as a crucial precursor in the synthesis of novel drug candidates, especially in oncology and central nervous system (CNS) therapeutic areas.
• Agrochemical Research: Used in the development of new pesticides and herbicides, leveraging its halogenated benzamide structure for biological activity.
• Chemical Synthesis Building Block: Employed in organic synthesis for constructing more complex molecules in research and scale-up laboratories.
• Material Science: Potential use in the development of specialty polymers and advanced organic electronic materials.
• Academic & Contract Research: Utilized in universities and CROs (Contract Research Organizations) for methodological studies and discovery chemistry.

Basic Information

Item	Detail
Product Name	n-(4-Bromo-2-Fluorophenyl)-3-Methylbenzamide
CAS No.	519017-68-6
Molecular Formula	C14H11BrFNO
Molecular Weight	308.15 g/mol
Synonyms	4'-Bromo-2'-fluoro-3-methylbenzanilide; 3-Methyl-N-(4-bromo-2-fluorophenyl)benzamide; N-(4-Bromo-2-fluorophenyl)-3-methyl-benzamide; Benzamide, N-(4-bromo-2-fluorophenyl)-3-methyl-; 519017-68-6
EINECS	Contact for details

Quality Control

Our n-(4-Bromo-2-Fluorophenyl)-3-Methylbenzamide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications are available upon request, supporting compliance with cGMP and ICH guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated place at controlled room temperature (typically 15-25°C). The product should be kept under inert atmosphere if long-term storage is required to prevent degradation.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Melting Point	Contact for details
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.